Evaluation of the cannabinoid CB 2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB 2 receptor absence in the rat central nervous system

Author： Griffin G.   Wray E.J.   Tao Q.   McAllister S.D.   Rorrer W.K.   Aung M.   Martin B.R.   Abood M.E.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.377, Iss.1, 1999-07, pp. : 117-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands

By  

Current Medicinal Chemistry, Vol. 21, Iss. 2, 2014-01 ,pp. : 187-203

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid CB1 and CB2 Receptor Ligand Specificity and the Development of CB2-Selective Agonists

By  

Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. : 1428-1443

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Selective Ligands for the Cannabinoid CB2 Receptor

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 3, 2008-01 ,pp. : 187-204

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Cannabinoid CB2 Receptor: Mutations, Modeling and Development of CB2 Selective Ligands

By  

Current Medicinal Chemistry, Vol. 12, Iss. 10, 2005-05 ,pp. : 1217-1237

Bentham Science Publishers

Access to resources Recommend Favorite

The cannabinoid CB 1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus

By Tzavara E.T.   Perry K.W.   Rodriguez D.E.   Bymaster F.P.   Nomikos G.G.  

European Journal of Pharmacology, Vol. 426, Iss. 3, 2001-08 ,pp. : 3-4

Elsevier

Access to resources Recommend Favorite